Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MMP9 | P14780 | 1/20 | 0.39 |
| ▸ | MMP8 | P22894 | 1/20 | 0.39 |
| ▸ | MMP14 | P50281 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9934509 | 0.90 | CYP3A4 (0.61) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL17779514 | 0.89 | CYP3A4 (0.71) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL18314760 | 0.88 | CYP3A4 (0.73) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL18314802 | 0.88 | CYP3A4 (0.73) | CYP3A4TSHRATMTDP1RECQL | |
| Acetic Acid SCHEMBL9932921 | 0.86 | CYP3A4 (0.57) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL29268656 | 0.85 | CYP3A4 (0.69) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL11668677 | 0.85 | CYP3A4 (0.73) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL26969204 | 0.84 | CYP3A4 (0.77) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL7775743 | 0.84 | CYP3A4 (0.68) | CYP3A4TSHRATMTDP1RECQL | |
| SCHEMBL30792599 | 0.84 | DNM1 (0.52) | CYP3A4TSHRATMTDP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9458373-B2 | Composition and method for reducing hydrate agglomeration | ECOLAB USA INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-9458373-B2 | Composition and method for reducing hydrate agglomeration | ECOLAB USA INC. (US) | 2016-10-04 | — | — | US | disclosed |
| US-9458373-B2 | Composition and method for reducing hydrate agglomeration | ECOLAB USA INC. (US) | 2016-10-04 | — | — | US | disclosed |
| EP-2651877-B1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | NALCO CO (US) | 2016-03-09 | — | — | EP | disclosed |
| US-8618025-B2 | Composition and method for reducing hydrate agglomeration | NALCO COMPANY (US) | 2013-12-31 | — | — | US | disclosed |
| EP-2651877-A2 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | Nalco Company (US) | 2013-10-23 | — | — | EP | disclosed |
| US-20120157351-A1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | APERGY ESP SYSTEMS, LLC | 2012-06-21 | — | — | US | disclosed |
| US-20120157351-A1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | APERGY ESP SYSTEMS, LLC | 2012-06-21 | — | — | US | disclosed |
| US-20120157351-A1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | APERGY ESP SYSTEMS, LLC | 2012-06-21 | — | — | US | disclosed |
| WO-2012082815-A2 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | NALCO COMPANY (US) | 2012-06-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157351-A1 | COMPOSITION AND METHOD FOR REDUCING HYDRATE AGGLOMERATION | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AQP1, AQP3 | CYP3A4 2227/4885TSHR 3665/4885ATM 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.